GLPwatch
Trials (2167)
Page 36 of 37.
- A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
- Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
- Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers
- Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
- Binge Eating Liraglutide Intervention
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
- Safety and Tolerability of Liraglutide in Healthy Male Volunteers
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
- Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
- A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
- A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- Chinese, Overweight or Obesity, Real-World Registry Study
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
- Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
- A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity
- In-patient Study in Patients With Type 2 Diabetes Mellitus
- POSE2.0 With GLP-1 Agonist for Obesity Management
- Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
- A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Impact of Exenatide on Sleep in Type 2 Diabetes
- Replication of the LEADER Diabetes Trial in Healthcare Claims
- The Evira Study: Additional Support During Obesity Treatment
- Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
- Effect of Gelofusine on GLP1-receptor Imaging
- A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
- Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
- Semaglutide and Physical Activity for Obesity and Multimorbidity
- A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
- A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- Incretin Effect on the Immunological Phenotype
- A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
- A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
- A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
- Role Of Metabolic Adaptation In Weight Regain
- GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
- TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
- Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
- A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
- VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
- Phase 1 Study to Evaluate the Safety and Tolerability of VK2735